INTERNATIONAL PATENT: CORCEPT THERAPEUTICS INCORPORATED FILES APPLICATION FOR "CONCOMITANT ADMINISTRATION OF MIRICORILANT WITH CYP2C19 INHIBITORS"

GENEVA, Aug. 26 -- CORCEPT THERAPEUTICS INCORPORATED (101 Redwood Shores ParkwayRedwood City, California 94065) filed a patent application (PCT/US2025/015378) for "CONCOMITANT ADMINISTRATION OF MIRICORILANT WITH CYP2C19 INHIBITORS" on Feb 11, 2025. With publication no. WO/2025/174742, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CUSTODIO, Joseph (c/o Corcept Therapeutics Incorporated101 Redwood Shores ParkwayRedwood City, California 94065), KUNTA, Jeevan (c/o Corcept Therapeutics Incorporated101 Redwood Shores ParkwayR...